Junctional adhesion molecule-A deficient mice are protected from severe experimental autoimmune encephalomyelitis
- PMID: 38566526
- DOI: 10.1002/eji.202350761
Junctional adhesion molecule-A deficient mice are protected from severe experimental autoimmune encephalomyelitis
Abstract
In multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE), early pathological features include immune cell infiltration into the central nervous system (CNS) and blood-brain barrier (BBB) disruption. We investigated the role of junctional adhesion molecule-A (JAM-A), a tight junction protein, in active EAE (aEAE) pathogenesis. Our study confirms JAM-A expression at the blood-brain barrier and its luminal redistribution during aEAE. JAM-A deficient (JAM-A-/-) C57BL/6J mice exhibited milder aEAE, unrelated to myelin oligodendrocyte glycoprotein-specific CD4+ T-cell priming. While JAM-A absence influenced macrophage behavior on primary mouse brain microvascular endothelial cells (pMBMECs) under flow in vitro, it did not impact T-cell extravasation across primary mouse brain microvascular endothelial cells. At aEAE onset, we observed reduced lymphocyte and CCR2+ macrophage infiltration into the spinal cord of JAM-A-/- mice compared to control littermates. This correlated with increased CD3+ T-cell accumulation in spinal cord perivascular spaces and brain leptomeninges, suggesting JAM-A absence leads to T-cell trapping in central nervous system border compartments. In summary, JAM-A plays a role in immune cell infiltration and clinical disease progression in aEAE.
Keywords: Blood–brain barrier; Experimental autoimmune encephalomyelitis; Junctional adhesion molecule A; Macrophages; T cells.
© 2024 The Authors. European Journal of Immunology published by Wiley‐VCH GmbH.
References
-
- Liebner, S., Dijkhuizen, R. M., Reiss, Y., Plate, K. H., Agalliu, D. and Constantin, G., Functional morphology of the blood–brain barrier in health and disease. Acta. Neuropathol. 2018. 135: 311–336.
-
- Engelhardt, B., Vajkoczy, P. and Weller, R. O., The movers and shapers in immune privilege of the CNS. Nat. Immunol. 2017. 18: 123–131.
-
- Hannocks, M. J., Zhang, X., Gerwien, H., Chashchina, A., Burmeister, M., Korpos, E., Song, J. et al., The gelatinases, MMP‐2 and MMP‐9, as fine tuners of neuroinflammatory processes. Matrix Biol. 2019. 75–76: 102–113.
-
- Owens, T., Bechmann, I. and Engelhardt, B., Perivascular spaces and the two steps to neuroinflammation. J. Neuropathol. Exp. Neurol. 2008. 67: 1113–1121.
-
- Marchetti, L. and Engelhardt, B., Immune cell trafficking across the blood‐brain barrier in the absence and presence of neuroinflammation. Vasc. Biol. 2020. 2: H1–18.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials